Metabolic Syndrome Skews Oncotype DX Reliability

SAN ANTONIO (IMNG) - Metabolic syndrome is a potent independent risk factor for breast cancer recurrence in patients who are otherwise at low risk, based on a widely used 21-gene recurrence score assay....
Source: OncologySTAT Latest News - Category: Cancer & Oncology Source Type: news